5 results on '"Bock, Carly"'
Search Results
2. Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility ― Four U.S. Metropolitan Areas, February 26–April 1, 2020
- Author
-
Lasry, Arielle, Kidder, Daniel, Hast, Marisa, Poovey, Jason, Sunshine, Gregory, Winglee, Kathryn, Zviedrite, Nicole, Ahmed, Faruque, Ethier, Kathleen A., Clodfelter, Catherine, Howard-Williams, Mara, Hulkower, Rachel, Jeong, Gi, Landsman, Lisa, McCord, Russell, Moreland, Amanda, Shelburne, Julia, Billioux, Alexander, Hand, Julie, Kanter, Joseph, Smith, Andrew, Sokol, Theresa, Duchin, Jeffrey S., Fagalde, Meaghan S., Pogosjans, Sargis, Brown, Robert, Huang, Sandra, Moss, Nicholas, Pan, Erica, Shemsu, Munira, Yette, Emily, Bock, Carly, Curtis-Robles, Rachel, Lockett, Cassius, Morrow, Scott, Sallenave, Catherine, Santora, Lisa, and Willis, Matthew
- Subjects
Health (social science) ,Time Factors ,Urban Population ,Epidemiology ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,Community organization ,Pneumonia, Viral ,Psychological intervention ,Public policy ,Public Policy ,01 natural sciences ,Proxy (climate) ,Etiquette ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Pandemic ,Medicine ,Humans ,030212 general & internal medicine ,Full Report ,0101 mathematics ,Socioeconomics ,Pandemics ,media_common ,business.industry ,Social distance ,010102 general mathematics ,COVID-19 ,General Medicine ,Metropolitan area ,United States ,Communicable Disease Control ,business ,Coronavirus Infections - Abstract
Community mitigation activities (also referred to as nonpharmaceutical interventions) are actions that persons and communities can take to slow the spread of infectious diseases. Mitigation strategies include personal protective measures (e.g., handwashing, cough etiquette, and face coverings) that persons can use at home or while in community settings; social distancing (e.g., maintaining physical distance between persons in community settings and staying at home); and environmental surface cleaning at home and in community settings, such as schools or workplaces. Actions such as social distancing are especially critical when medical countermeasures such as vaccines or therapeutics are not available. Although voluntary adoption of social distancing by the public and community organizations is possible, public policy can enhance implementation. The CDC Community Mitigation Framework (1) recommends a phased approach to implementation at the community level, as evidence of community spread of disease increases or begins to decrease and according to severity. This report presents initial data from the metropolitan areas of San Francisco, California; Seattle, Washington; New Orleans, Louisiana; and New York City, New York* to describe the relationship between timing of public policy measures, community mobility (a proxy measure for social distancing), and temporal trends in reported coronavirus disease 2019 (COVID-19) cases. Community mobility in all four locations declined from February 26, 2020 to April 1, 2020, decreasing with each policy issued and as case counts increased. This report suggests that public policy measures are an important tool to support social distancing and provides some very early indications that these measures might help slow the spread of COVID-19.
- Published
- 2020
3. Uncovering Buffered Pleiotropy: A Genome-Scale Screen formel-28Genetic Interactors inCaenorhabditis elegans
- Author
-
Fernandez, Anita G, primary, Mis, Emily K, additional, Lai, Allison, additional, Mauro, Michael, additional, Quental, Angela, additional, Bock, Carly, additional, and Piano, Fabio, additional
- Published
- 2014
- Full Text
- View/download PDF
4. Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017.
- Author
-
Burke RM, Tate JE, Barin N, Bock C, Bowen MD, Chang D, Gautam R, Han G, Holguin J, Huynh T, Pan CY, Quenelle R, Sallenave C, Torres C, Wadford D, and Parashar U
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, California epidemiology, Child, Child, Preschool, Humans, Infant, Middle Aged, Rotavirus Infections prevention & control, Rotavirus Vaccines administration & dosage, Young Adult, Assisted Living Facilities, Child Day Care Centers, Disease Outbreaks statistics & numerical data, Health Facilities, Rotavirus Infections epidemiology
- Abstract
Before the introduction of rotavirus vaccine in 2006, rotavirus was the most common cause of severe diarrhea among U.S. children (1). Currently, two rotavirus vaccines are licensed for use in the United States, both of which have demonstrated good field effectiveness (78%-89%) against moderate to severe rotavirus illness (2), and the use of these vaccines has substantially reduced the prevalence of rotavirus in the United States (3). However, the most recent national vaccine coverage estimates indicate lower full rotavirus vaccine-series completion (73%) compared with receipt of at least 3 doses of vaccines containing diphtheria, tetanus, and pertussis antigens (95%), given on a similar schedule to rotavirus vaccines (4). In the postvaccine era in the United States, rotavirus activity persists in a biennial pattern (3). This report describes three rotavirus outbreaks that occurred in California in 2017. One death was reported; however, the majority of cases were associated with mild to moderate illness, and illness occurred across the age spectrum as well as among vaccinated children. Rotavirus vaccines are designed to mimic the protective effects of natural infection and are most effective against severe rotavirus illness (2). Even in populations with high vaccination coverage, some rotavirus infections and mild to moderate illnesses will occur. Rotavirus vaccination should continue to be emphasized as the best means of reducing disease prevalence in the United States., Competing Interests: No conflicts of interest were reported.
- Published
- 2018
- Full Text
- View/download PDF
5. Uncovering buffered pleiotropy: a genome-scale screen for mel-28 genetic interactors in Caenorhabditis elegans.
- Author
-
Fernandez AG, Mis EK, Lai A, Mauro M, Quental A, Bock C, and Piano F
- Subjects
- Animals, Caenorhabditis elegans growth & development, Caenorhabditis elegans Proteins antagonists & inhibitors, Caenorhabditis elegans Proteins metabolism, Chromosome Segregation, DNA-Binding Proteins, Dyneins metabolism, Heterozygote, Larva genetics, Larva metabolism, Nuclear Pore genetics, Nuclear Pore metabolism, Nuclear Proteins antagonists & inhibitors, Nuclear Proteins metabolism, Phenotype, RNA Interference, Transport Vesicles metabolism, Caenorhabditis elegans genetics, Caenorhabditis elegans Proteins genetics, Genetic Pleiotropy, Genome, Nuclear Proteins genetics
- Abstract
mel-28 (maternal-effect-lethal-28) encodes a conserved protein required for nuclear envelope function and chromosome segregation in Caenorhabditis elegans. Because mel-28 is a strict maternal-effect lethal gene, its function is required in the early embryo but appears to be dispensable for larval development. We wanted to test the idea that mel-28 has postembryonic roles that are buffered by the contributions of other genes. To find genes that act coordinately with mel-28, we did an RNA interference-based genetic interaction screen using mel-28 and wild-type larvae. We screened 18,364 clones and identified 65 genes that cause sterility in mel-28 but not wild-type worms. Some of these genes encode components of the nuclear pore. In addition we identified genes involved in dynein and dynactin function, vesicle transport, and cell-matrix attachments. By screening mel-28 larvae we have bypassed the requirement for mel-28 in the embryo, uncovering pleiotropic functions for mel-28 later in development that are normally provided by other genes. This work contributes toward revealing the gene networks that underlie cellular processes and reveals roles for a maternal-effect lethal gene later in development.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.